Goodbye to one-size-fits-all solutions to rein in pain
Cholesterol-reducing statin drugs could relieve ulcerative colitis
An intensive care team takes on COVID-19
How Stanford physicians and researchers prepare patients to thrive after surgery
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
How physicians are fueling the opioid epidemic